Kaydan Wealth Management
ABBV icon

Kaydan Wealth Management’s AbbVie ABBV Stock Holding History

Kaydan Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$258K Sell
985
-192
-16% -$49.2K 0.09% 102
2026
Q2 		$296K Sell
1,177
-85
-7% -$18.3K 0.09% 99
2026
Q1 		$274K Buy
1,262
+94
+8% +$20.9K 0.09% 92
2025
Q4 		$267K Buy
1,168
+4
+0.3% +$911 0.08% 94
2025
Q3 		$270K Buy
1,164
+5
+0.4% +$1.02K 0.08% 96
2025
Q2 		$215K Buy
1,159
+4
+0.3% +$743 0.07% 105
2025
Q1 		$242K Buy
1,155
+5
+0.4% +$972 0.08% 96
2024
Q4 		$204K Buy
1,150
+4
+0.3% +$735 0.07% 104
2024
Q3 		$226K Buy
+1,146
New +$214K 0.07% 102
2024
Q2 		– Sell
-1,138
Closed -$207K – 104
2024
Q1 		$207K Buy
+1,138
New +$196K 0.07% 103

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Kaydan Wealth Management's ABBV Position: Q3 2026 in Review

Kaydan Wealth Management reduced its AbbVie (ABBV) stake by 16% in Q3 2026, selling an estimated $49.2K and leaving 985 shares worth $258K. The position accounts for 0.09% of the portfolio, ranked #102.

Kaydan Wealth Management first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $296K in Q2 2026. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Kaydan Wealth Management held 985 shares of AbbVie worth $258K as of Q3 2026.
  • Kaydan Wealth Management sold 192 AbbVie shares in Q3 2026, an estimated $49.2K.
  • AbbVie made up 0.09% of Kaydan Wealth Management's portfolio in Q3 2026, its #102 holding.
  • Kaydan Wealth Management first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • Kaydan Wealth Management's AbbVie position peaked at $296K in Q2 2026.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Kaydan Wealth Management's 13F filing for Q3 2026, filed 8 Oct 2026.